Cathie Wood’s Latest Portfolio: 5 Stocks Under $10

2. RedHill Biopharma Ltd. (NASDAQ:RDHL)

Number of Hedge Fund Holders: 4  

Share Price as of May 16: $1.02

RedHill Biopharma Ltd. (NASDAQ:RDHL) is a biopharma firm that focuses on the development of medicines for gastrointestinal and infectious diseases. Securities filings show that ARK owned 861,798 shares of RedHill Biopharma Ltd. (NASDAQ:RDHL) at the end of March 2022, worth $2.1 million. The company is a new addition to the portfolio compared to filings for the fourth quarter of 2021. However, the firm has featured in the ARK portfolio, with a minor exception in late 2021, since early 2018. 

On March 15, RedHill Biopharma Ltd. (NASDAQ:RDHL) announced that it had inked an exclusive license agreement with Kukbo, a Seoul-based conglomerate, for the commercialization of oral opaganib, a drug for the treatment of COVID-19. 

At the end of the fourth quarter of 2021, 4 hedge funds in the database of Insider Monkey held stakes worth $965,000 in RedHill Biopharma Ltd. (NASDAQ:RDHL), up from 3 in the preceding quarter worth $443,000.